The R&D laboratory and pilot production workshop of Xinwen Biopharmaceutical Technology (Jiashan) Co., Ltd. for innovative transdermal drug delivery formulations have been officially put into use recently, marking a further improvement of Xinwen Biotech's research and production capabilities in the field of transdermal drug delivery.

The laboratory and production workshop cover an area of approximately 1000 square meters and are constructed and managed according to GMP requirements. Advanced equipment and technology are used to carry out the entire process of research from innovative transdermal drug formulations to pilot production. At the same time, the laboratory and workshop are equipped with high-quality laboratory personnel and engineers, with rich experience in the research and production of innovative transdermal drug delivery formulations.

Xinwen Biotechnology is committed to the research of innovative transdermal drug delivery formulations. It has an independent intellectual property research platform for transdermal drug delivery formulations, and has leading domestic production technology and processes for transdermal drug delivery formulations. Its product pipeline covers multiple treatment fields and the field of general health.

The introduction of new laboratories and workshops will provide more comprehensive technical and facility support for the research and production of innovative transdermal drug delivery formulations by Xinwen Bio, while also promoting the sustained development and innovation of Xinwen Bio in the field of transdermal drug delivery. Xinwen Biotechnology will continue to increase its research efforts in the field of transdermal drug delivery, committed to providing more advanced and efficient treatment methods for clinical medicine, and making its own contribution to the cause of human health.